End-point definition and trial design to advance tuberculosis vaccine development

Tuberculosis (TB) remains a leading infectious cause of death worldwide and the coronavirus disease 2019 pandemic has negatively impacted the global TB burden of disease indicators. If the targets of TB mortality and incidence reduction set by the international community are to be met, new more effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Basteiro, Alberto L., White, Richard G., Tait, Dereck, Schmidt, Alexander C., Rangaka, Molebogeng X., Quaife, Matthew, Nemes, Elisa, Mogg, Robin, Hill, Philip C., Harris, Rebecca C., Hanekom, Willem A., Frick, Mike, Fiore-Gartland, Andrew, Evans, Tom, Dagnew, Alemnew F., Churchyard, Gavin, Cobelens, Frank, Behr, Marcel A., Hatherill, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488660/
https://www.ncbi.nlm.nih.gov/pubmed/35675923
http://dx.doi.org/10.1183/16000617.0044-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488660/
https://www.ncbi.nlm.nih.gov/pubmed/35675923
http://dx.doi.org/10.1183/16000617.0044-2022

Ejemplares similares